Abstract:Introduction: Patients with hematologic diseases are at high risk for invasive fungal infections (IFI).The diagnosis of IFI is difficult with specificity as low as 20%–30%. The currently used diagnostic methods for IFI such as CT scan, fungal cultures, and antigen detection are insufficient in reaching a definitive diagnosis. Histopathology with tissue diagnosis is the method of choice. CT-guided percutaneous lung biopsy (CT-PCLB) can provide pathological diagnosis and hence significant guidance for clinical management. Objectives: To evaluate the sensitivity and safety of CT-PCLB for the diagnosis of pulmonary fungal infections in patients with hematologic diseases. Patients and Method: We retrospectively studied 16 patients hospitalized in our department from April 2005 to December 2006 who were clinically regarded as having pulmonary fungal infections by clinical symptoms and imaging and who subsequently underwent CT-PCLB. Among the 16 patients, 10 had AML, 2 had ALL, 2 had ITP, 1 had MDS and 1 had multiple myeloma. At the time of percutaneous lung biopsies, median WBC was 3.2 k/ul (range 0.7–7.2 k/ul), median platelets were 82 k/ul (range 32–453 k/ul). Peripheral blood cultures were performed in all patients. Eight patients who had symptoms of cough and expectoration also received sputum culture for at least three times. Of the 16 patients, 10 were diagnosed with fungal infections (8 aspergillus’s and 2 mold fungi), 4 with chronic organizing pneumonitis, 1 with tuberculosis, and 1 with pneumocystis carinii. All tissue diagnoses were from histological examination with samples obtained from CT-PCLB. However, the results of blood cultures and sputum cultures were negative in these 8 patients. CT-PCLB diagnosed 10 out of 16 patients for a fungal infection rate of 63%. The biopsy-induced complications encountered were pneumothorax in 3/16 (19%) and hemoptysis in 6% (1/16). No surgical interventions were needed for the 3 patients with pneumothoraxes that resolved spontaneous under close observation. Antifungal agents (such as voriconazole) had been given to 8 patients diagnosed as aspergillus infection and all patients had a complete or partial response by CT imaging. However, 2 patients who received broad-spectrum antibacterial antibiotics showed clinical improvement, which indicated possible false negative diagnoses for fungal infections by CT-PCLB. Conclusion: CT-guided percutaneous lung biopsy (CT-PCLB) was a safe, sensitive and specific method for the diagnosis of pulmonary fungal infections in patients with hematologic diseases. Its definitive value should be tested in a prospective clinical trial.

[The value of the current diagnostic criteria of pulmonary invasive fungal infection after allogeneic hematopoietic stem cell transplantation]

Relationship Between Gene Polymorphism of Recipient/Donor Immune Pathway and Invasive Fungal Infection after Allogeneic Hematopoietic Stem Cell Transplantation

Invasive Fungal Infection in Allogeneic Hematopoietic Stem Cell Transplant Recipients: Single Center Experiences of 12 Years

Clinical analysis of metagenome next-generation sequencing for diagnosing invasive fungal disease in patients with early stage of hematopoietic stem cell transplantation

Clinical Analysis of 13 Cases with Fungal Pulmonary Infectious after Allogeneic Hematopoietic Stem Cell Transplantation

[The Prevalence and Risk Factors of Invasive Fungal Infection in Hematopoietic Stem Cell Transplant Recipients].

Utility of CT Assessment in Hematology Patients with Invasive Aspergillosis: a Post-Hoc Analysis of Phase 3 Data

[Risk Factors and Outcome of Invasive Fungal Infection in 79 Patients Received Allogeneic Hematopoietic Cell Transplantation].

Clinical Analysis of Recipients of Allo1geneic Hematopoietic Stem Cell Transplantation with a History of Pulmonary Invasive Fungal Disease

Imaging Features of Chest CT and Prognosis of Proven Pulmonary Invasive Fungal Disease After Hematopoietic Stem Cell Transplantation

Affecting factors analysis of pulmonary invasive fungal infection in patients after allogeneic haemopoietic stem cell transplantation

An Analysis of 6 Patients with Pulmonary Fungal Infection after Allogeneic Haemopoietic Stem Cell Transplantation

Relationship between T Lymphocyte Reconstitution and Invasive Fungal Infections in Allogeneic Hematopoietic Stem Cell Transplant Recipients

The Value Of Ct-Guided Percutaneous Lung Biopsy In The Diagnosis Of Pulmonary Fungal Infections In Patients With Hematologic Diseases

Positive results of serum galactomannan assays and pulmonary computed tomography predict the higher response rate of empirical antifungal therapy in patients undergoing allogeneic hematopoietic stem cell transplantation.

Current status and new experimental diagnostic methods of invasive fungal infections after hematopoietic stem cell transplantation

Epidemiology, management, and outcome of invasive fungal disease in patients undergoing hematopoietic stem cell transplantation in China: a multicenter prospective observational study.

Pulmonary Infection after Allo-Transplantation: Fungus or Tuberculosis? 2 Case Report.

Invasive Fungal Disease in Patients Undergoing Allogeneic Hematopoietic Stem Cell Transplantation in China: A Multicenter Epidemiological Study (CAESAR 2.0)

Pre-existing invasive fungal infection is not a contraindication for allogeneic HSCT for patients with hematologic malignancies: a CIBMTR study

The Incidence and Risk Factors of Invasive Fungal Infection after Haploidentical Haematopoietic Stem Cell Transplantation Without in Vitro T-cell Depletion